Literature DB >> 10359362

Tamoxifen and contralateral breast cancer.

R O'Regan1, V C Jordan, W J Gradishar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10359362     DOI： 10.1016/s1072-7515(99)00057-5

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN： 1072-7515            Impact factor:   6.113


× No keyword cloud information.
  1 in total

1.  Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.

Authors:  Rikke Langballe; Lene Mellemkjær; Kathleen E Malone; Charles F Lynch; Esther M John; Julia A Knight; Leslie Bernstein; Jennifer Brooks; Michael Andersson; Anne S Reiner; Xiaolin Liang; Meghan Woods; Patrick J Concannon; Jonine L Bernstein
Journal:  Breast Cancer Res       Date:  2016-07-12       Impact factor: 6.466
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.